News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
138 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (2)
2 (10)
3 (262)
4 (319)
5 (322)
6 (403)
7 (138)
8 (5)
9 (6)
10 (288)
11 (270)
12 (233)
13 (253)
14 (122)
15 (4)
16 (3)
17 (180)
18 (202)
19 (174)
20 (201)
21 (97)
22 (2)
23 (5)
24 (187)
25 (247)
26 (232)
27 (214)
28 (80)
29 (13)
30 (7)
31 (244)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
Genentech’s Tecentriq Comes Up Short in Phase III Breast Cancer Study
Genentech’s checkpoint inhibitor Tecentriq combined with chemotherapy failed to hit the mark in a Phase III metastatic triple-negative breast cancer study.
August 7, 2020
·
2 min read
·
Alex Keown
Policy
FDA Accepts BLA for Biogen’s Alzheimer’s Drug, Grants Priority Review
The FDA set a PDUFA target date of March 7, 2021 for aducanumab, Biogen said.
August 7, 2020
·
2 min read
·
Alex Keown
Business
Aerovate Therapeutics Launches with $72 Million and Repurposed Cancer Drug for PAH
Aerovate Therapeutics secured $72.6 million in Series A funding to advance trials of AV-101, an inhaled, dry powder aerosol version of Novartis’ cancer drug Gleevec (imatinib) in a repurposed effort to treat pulmonary arterial hypertension (PAH).
August 7, 2020
·
3 min read
·
Alex Keown
Genetown
Vigeo’s Tumor Microenvironment Platform Expands Indications and Combo Therapy Possibilities
Vigeo Therapeutics is expanding indications for its tumor microenvironment (TME)-targeting oncology platform, which inhibits tumor growth by reprogramming normal cells that were recruited and coopted by a tumor.
August 7, 2020
·
5 min read
·
Gail Dutton
Business
Kite, a Gilead Company, Looks to Expand Its Cell Therapy Maryland Operations
Maryland has become a key part of the strategy for Kite, a Gilead company, and its mission to find a cure for cancer.
August 7, 2020
·
3 min read
·
Alex Keown
Business
Novavax and SIPL to Develop 1 Billion COVID-19 Vaccine Doses for India, Other Countries
Novavax said the agreement will allow for the development and distribution of NVX‑CoV2373, a recombinant vaccine engineered from the genetic sequence of SARS-CoV-2, in India and in low- and middle-income countries.
August 7, 2020
·
2 min read
·
Alex Keown
Policy
White House Executive Order Aims to Boost Domestic Production of ‘Essential Drugs’
In an aim to create a strong domestic supply chain, President Donald Trump signed an Executive Order on Thursday that calls for federal agencies to purchase “essential drugs” and medical supplies that are produced in the United States, rather than from abroad as is the current practice.
August 7, 2020
·
3 min read
·
Alex Keown
Tooth Filling Materials Market is still evolving by upgrading and implementing newer technologies
Tooth filling material is used when a tooth gets damaged, detached, or in the areas from where the cavity is removed.
August 7, 2020
·
7 min read
Surgical Face Masks Market: Focus on Enhancing Manufacturing Capabilities by Key Players to Propel Global Market
According to the report, the global surgical face masks market was valued at ~US$ 2 Bn in 2019 and is projected to expand at a high CAGR during the forecast period.
August 7, 2020
·
4 min read
Peptide Therapeutics Market: Immunopeptides Segment to exhibit Rapid Growth in Global Market
Transparency Market Research has published a new report titled, ‘Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
August 7, 2020
·
7 min read
1 of 14
Next